Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

NCT00224302 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Psychotic Disorders

Interventions

DRUG: Duloxetine

Sponsor

Central Institute of Mental Health, Mannheim